These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27090917)

  • 1. Can the upper inner side of the thigh become a new option for insulin injection?
    Yuan J; Chen Y; Xuan Y; Cao L; Zhu J; Wang F; Zhou X; Ye Q; Liao L; Zheng Y; Zhou Q; Chen X; Chen M; Zhou W
    Curr Med Res Opin; 2016 Jul; 32(7):1319-24. PubMed ID: 27090917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial.
    Heise T; Nosek L; Dellweg S; Zijlstra E; Præstmark KA; Kildegaard J; Nielsen G; Sparre T
    Diabetes Obes Metab; 2014 Oct; 16(10):971-6. PubMed ID: 24720741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
    McKay M; Compion G; Lytzen L
    Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.
    Gibney MA; Arce CH; Byron KJ; Hirsch LJ
    Curr Med Res Opin; 2010 Jun; 26(6):1519-30. PubMed ID: 20429833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy.
    Hirsch L; Byron K; Gibney M
    Diabetes Technol Ther; 2014 Dec; 16(12):867-73. PubMed ID: 25329935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous tissue thickness in children with type 1 diabetes.
    Shin H; Kim MJ
    J Adv Nurs; 2006 Apr; 54(1):29-34. PubMed ID: 16553688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents.
    Hofman PL; Lawton SA; Peart JM; Holt JA; Jefferies CA; Robinson E; Cutfield WS
    Diabet Med; 2007 Dec; 24(12):1400-5. PubMed ID: 18042081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The abdomen, thigh, and arm as sites for subcutaneous sodium heparin injections.
    Fahs PS; Kinney MR
    Nurs Res; 1991; 40(4):204-7. PubMed ID: 1857645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thigh may not be suitable as an injection site for patients self-injecting sumatriptan.
    Frid A; Hardebo JE
    Neurology; 1997 Aug; 49(2):559-61. PubMed ID: 9270596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How painful is intensive insulin therapy?].
    Lee DM
    Z Gesamte Inn Med; 1992 Jun; 47(6):266-9. PubMed ID: 1642027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection.
    Lo Presti D; Ingegnosi C; Strauss K
    Pediatr Diabetes; 2012 Nov; 13(7):525-33. PubMed ID: 22583390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients.
    Clauson PG; Linde B
    Diabetes Care; 1995 Jul; 18(7):986-91. PubMed ID: 7555561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous adipose tissue thickness in adults - correlation with BMI and recommendations for pen needle lengths for subcutaneous self-injection.
    Ludescher B; Rommel M; Willmer T; Fritsche A; Schick F; Machann J
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):786-90. PubMed ID: 21623860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the ideal injection techniques when using 5-mm needles in children and adults.
    Hofman PL; Derraik JG; Pinto TE; Tregurtha S; Faherty A; Peart JM; Drury PL; Robinson E; Tehranchi R; Donsmark M; Cutfield WS
    Diabetes Care; 2010 Sep; 33(9):1940-4. PubMed ID: 20585002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin administration: selecting the appropriate needle and individualizing the injection technique.
    Hansen B; Matytsina I
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1395-406. PubMed ID: 21864222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients.
    Le Floch JP; Herbreteau C; Lange F; Perlemuter L
    Diabetes Care; 1998 Sep; 21(9):1502-4. PubMed ID: 9727898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous Bioavailability of Taspoglutide at 3 Different Injection Sites in Healthy Overweight/Obese Subjects.
    Sturm-Pellanda C; Abt M; Sanwald-Ducray P; Schmitt C
    Clin Ther; 2015 Nov; 37(11):2439-48. PubMed ID: 26412802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility study of vertical subcutaneous injection of insulin with an insulin pen injector in diabetic patients with normal body mass index.
    Zhou L; Fan YF; Lu XQ; Ye JP; Ye MH
    J Int Med Res; 2010; 38(2):669-73. PubMed ID: 20515581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.